Hyper-inflammatory profile and immunoparalysis in patients with severe Legionnaires' disease.
IL-18
LPS stimulation
Legionnaires’ disease
cytokines
hyper-inflammation
immune functional assays
immunoparalysis
severity
Journal
Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359
Informations de publication
Date de publication:
2023
2023
Historique:
received:
03
07
2023
accepted:
28
09
2023
medline:
16
11
2023
pubmed:
15
11
2023
entrez:
15
11
2023
Statut:
epublish
Résumé
Severe Legionnaires' disease (LD) can lead to multi-organ failure or death in 10%-30% of patients. Although hyper-inflammation and immunoparalysis are well described in sepsis and are associated with high disease severity, little is known about the immune response in LD. This study aimed to evaluate the immune status of patients with LD and its association with disease severity. A total of 92 hospitalized LD patients were included; 19 plasmatic cytokines and pulmonary Among the 84 patients, a higher secretion of plasmatic MCP-1, MIP1-β, IL-6, IL-8, IFN-γ, TNF-α, and IL-17 was observed in the patients with D0 and D8 MV. Multiparametric analysis showed that these seven cytokines were positively associated with the SOFA score. Upon conA stimulation, LD patients had a lower secretion capacity for 16 of the 19 quantified cytokines and a higher release of IL-18 and MCP-1 compared to HV. IL-18 secretion was higher in D0 and D8 MV patients. TNF-α secretion, measured after The present findings describe a hyper-inflammatory phase at the initial phase of
Identifiants
pubmed: 37965258
doi: 10.3389/fcimb.2023.1252515
pmc: PMC10641404
doi:
Substances chimiques
Interleukin-18
0
Tumor Necrosis Factor-alpha
0
Lipopolysaccharides
0
Cytokines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1252515Informations de copyright
Copyright © 2023 Allam, Mouton, Testaert, Ginevra, Fessy, Ibranosyan, Descours, Beraud, Guillemot, Chapalain, Albert-Vega, Richard, Argaud, Friggeri, Labeye, Jamilloux, Freymond, Venet, Lina, Doublet, Ader, Trouillet-Assant and Jarraud.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Crit Care Explor. 2021 Aug 10;3(8):e0508
pubmed: 34396145
Cytokine. 2008 Nov;44(2):298-303
pubmed: 18838275
Clin Microbiol Infect. 2009 Nov;15(11):1020-5
pubmed: 19438643
Immunol Invest. 2007;36(4):403-11
pubmed: 17691022
Trends Immunol. 2009 Oct;30(10):475-87
pubmed: 19781994
Apoptosis. 2017 Feb;22(2):295-305
pubmed: 27812767
J Immunol. 2006 May 15;176(10):6162-71
pubmed: 16670325
J Leukoc Biol. 2017 Feb;101(2):543-554
pubmed: 27630218
Eur J Clin Microbiol Infect Dis. 2009 Jan;28(1):55-60
pubmed: 18677519
Clin Immunol. 2020 Jan;210:108312
pubmed: 31760096
Virulence. 2022 Dec;13(1):160-173
pubmed: 35030980
J Leukoc Biol. 2017 Apr;101(4):841-849
pubmed: 27999148
Eur Respir J. 2012 Apr;39(4):963-70
pubmed: 22005914
Immunity. 2021 Nov 9;54(11):2450-2464
pubmed: 34758337
Front Immunol. 2018 Oct 16;9:2367
pubmed: 30386334
J Antimicrob Chemother. 2017 May 1;72(5):1502-1509
pubmed: 28204479
PLoS One. 2013 Apr 30;8(4):e62265
pubmed: 23646123
Cytometry B Clin Cytom. 2013 Jan-Feb;84(1):59-62
pubmed: 22987669
Nat Rev Immunol. 2013 Dec;13(12):862-74
pubmed: 24232462
Front Cell Infect Microbiol. 2023 May 03;13:1037850
pubmed: 37207185
Immunol Rev. 2016 Nov;274(1):330-353
pubmed: 27782333
PLoS One. 2017 Aug 3;12(8):e0182427
pubmed: 28771573
Clin Diagn Lab Immunol. 2003 Sep;10(5):813-20
pubmed: 12965910
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):2017-28
pubmed: 22278293
J Leukoc Biol. 2000 Jun;67(6):863-8
pubmed: 10857860
BMC Infect Dis. 2016 Feb 10;16:75
pubmed: 26864322
J Appl Microbiol. 2013 Jun;114(6):1725-33
pubmed: 23432908
J Infect. 2020 May;80(5):e23-e24
pubmed: 32145214
Lancet Respir Med. 2021 Jun;9(6):622-642
pubmed: 33965003
J Immunol. 2012 Nov 15;189(10):5073-81
pubmed: 23053510
Ann Intensive Care. 2023 Mar 12;13(1):17
pubmed: 36906875
Sci Rep. 2020 Sep 30;10(1):16136
pubmed: 32999313
Nat Rev Nephrol. 2018 Feb;14(2):121-137
pubmed: 29225343
Euro Surveill. 2017 Jul 6;22(27):
pubmed: 28703097
J Med Virol. 2021 Jan;93(1):250-256
pubmed: 32592501
Cell Rep. 2016 Sep 6;16(10):2777-2791
pubmed: 27568558
Infect Immun. 2005 Jan;73(1):352-61
pubmed: 15618172
Clin Respir J. 2019 Oct;13(10):605-613
pubmed: 31310442
Crit Care Med. 2022 Apr 1;50(4):565-575
pubmed: 34534131
Thorax. 2003 Jan;58(1):63-7
pubmed: 12511724
Lancet Infect Dis. 2020 Aug;20(8):e192-e197
pubmed: 32539990
Cell Host Microbe. 2020 Nov 11;28(5):683-698.e6
pubmed: 32841604
Crit Care. 2021 Apr 12;25(1):140
pubmed: 33845874
J Clin Lab Anal. 2016 Nov;30(6):1037-1043
pubmed: 27184083
JCI Insight. 2018 Mar 8;3(5):
pubmed: 29515037
Clin Diagn Lab Immunol. 1998 May;5(3):401-3
pubmed: 9605998
Lancet Respir Med. 2020 Dec;8(12):1233-1244
pubmed: 33075298
Infect Immun. 2009 May;77(5):1981-91
pubmed: 19237518
J Infect Dis. 2020 Jul 21;222(Suppl 2):S84-S95
pubmed: 32691839